BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29193277)

  • 1. Spectrophotometry and Ultracentrifugation for Measurement of Plasma Lipids in Dogs with Diabetes Mellitus.
    Seage EC; Drobatz KJ; Hess RS
    J Vet Intern Med; 2018 Jan; 32(1):93-98. PubMed ID: 29193277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
    Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
    Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of cholesterol loading of the low-density lipoprotein fraction in diabetic subjects without ultracentrifugation.
    Yoshino G; Iwai M; Matsuba K; Iwatani I; Matsushita M; Kazumi T; Baba S
    Diabetes Res Clin Pract; 1989 Aug; 7(2):155-7. PubMed ID: 2776655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome.
    Barkas F; Elisaf M; Liberopoulos E; Liontos A; Rizos EC
    Atherosclerosis; 2016 Apr; 247():58-63. PubMed ID: 26868509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults.
    Haslam DE; Chasman DI; Peloso GM; Herman MA; Dupuis J; Lichtenstein AH; Smith CE; Ridker PM; Jacques PF; Mora S; McKeown NM
    J Nutr; 2022 Nov; 152(11):2534-2545. PubMed ID: 36774119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study.
    Quispe R; Manalac RJ; Faridi KF; Blaha MJ; Toth PP; Kulkarni KR; Nasir K; Virani SS; Banach M; Blumenthal RS; Martin SS; Jones SR
    Atherosclerosis; 2015 Sep; 242(1):243-50. PubMed ID: 26232164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.
    Hermans MP; Sacks FM; Ahn SA; Rousseau MF
    Cardiovasc Diabetol; 2011 Feb; 10():20. PubMed ID: 21356116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia in diabetes: a population-based study in Bali.
    Suastika K; Semadi IMS; Dwipayana IMP; Saraswati MR; Gotera W; Budhiarta AAG; Matsumoto K; Kajiwara N; Taniguchi H
    Int J Gen Med; 2019; 12():313-321. PubMed ID: 31564954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of LDL apoB.
    Sniderman AD; Tremblay AJ; De Graaf J; Couture P
    Atherosclerosis; 2014 Jun; 234(2):373-6. PubMed ID: 24747110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B is not superior to non-high-density lipoprotein cholesterol for dyslipidemic classification of glycated hemoglobin-defined diabetic patients.
    Xie J; Hu S
    Medicine (Baltimore); 2018 Oct; 97(42):e12896. PubMed ID: 30335016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The apolipoprotein B concentration in gingival crevicular fluid increases in patients with diabetes mellitus.
    Noguchi E; Kato R; Ohno K; Mitsui A; Obama T; Hirano T; Itabe H; Yamamoto M
    Clin Biochem; 2014 Jan; 47(1-2):67-71. PubMed ID: 24095848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels.
    Hayashi T; Koba S; Ito Y; Hirano T
    Lipids Health Dis; 2017 Jan; 16(1):21. PubMed ID: 28125987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.
    Du Y; Sun H; Li Y; Shi X; Pei D; Qi D; Wang B
    Clin Lab; 2014; 60(8):1295-300. PubMed ID: 25185414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.
    Ren XY; Shi D; Ding J; Cheng ZY; Li HY; Li JS; Pu HQ; Yang AM; He CL; Zhang JP; Ma YB; Zhang YW; Zheng TZ; Bai YN; Cheng N
    Lipids Health Dis; 2019 Feb; 18(1):47. PubMed ID: 30744645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of apoB dyslipoproteinemia in Korean population.
    Moon HW; Park CM; Hong SN; Park S; Hur M; Yun YM
    Clin Biochem; 2013 Aug; 46(12):1041-1046. PubMed ID: 23685223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of alterations in plasma lipid profile levels in breast cancer.
    Franky Dhaval Shah ; Shilin Nandubhai Shukla ; Pankaj Manubhai Shah ; Patel HR; Prabhudas Shankerbhai Patel
    Integr Cancer Ther; 2008 Mar; 7(1):33-41. PubMed ID: 18292593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.